Early Morning Technical Insight: Bristol-Myers Squibb Co., Eli Lilly & Co.,
Endo Health Solutions Inc., and Allergan Inc.
LONDON, November 27, 2013
LONDON, November 27, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Tuesday, November 26, 2013, both the S&P 500 and the NASDAQ Composite
finished the day higher at 1,802.75, up 0.01%, and 4,017.75, up 0.58%,
respectively. The Dow Jones Industrial Average, on the other hand, closed flat
at 16,072.80. Shares in healthcare-drug makers ended on a lower note, even as
the broader market edged higher. The major movers in the sector included
Bristol-Myers Squibb Company (NYSE: BMY), Eli Lilly & Company (NYSE: LLY),
Endo Health Solutions Inc. (NASDAQ: ENDP), and Allergan Inc. (NYSE: AGN). All
these companies are tracked by AAAResearchReports.com. Download free technical
analysis and charting reports on BMY, LLY, ENDP, and AGN now at:
On Tuesday, shares in Bristol-Myers Squibb Co. declined by 1.84%, even as the
broader market posted gains. The company's shares closed the day at $51.88,
after trading between $51.35 and $52.87. A total of 10.31 million shares were
traded, which is above the daily average volume of 7.25 million. Despite
Tuesday's decline, the company's shares have gained 6.38% in the last one
month and 22.30% in the previous three months, outperforming the S&P 500,
which has advanced 2.44% and 8.81% during the respective periods. Further,
Bristol-Myers Squibb Co.'s stock is trading above its 50-day and 200-day
moving averages of $49.60 and $44.10, respectively. Download free research on
BMY today by registering at:
Eli Lilly & Co.'s stock oscillated between $50.54 and $51.45 before ending
Tuesday's session 1.56% lower at $50.54. A total of 5.52 million shares were
traded, which is below the daily average volume of 6.09 million. Despite
Tuesday's pullback, the company's shares have advanced 0.10% in the previous
three trading sessions, compared to a gain of 0.38% in the S&P 500 during the
same period. Moreover, Shares in Eli Lilly & Co.'s stock is trading above its
50-day moving average of $50.48. Sign up and have access to our free report on
Shares in Endo Health Solutions Inc. edged lower on Tuesday after hitting a
new 52-week high of $67.23. The company's shares closed the day at $66.97,
down 0.01% from the previous day's price of $66.98. A total of 1.06 million
shares were traded, which is below the daily average volume of 2.63 million.
Despite Tuesday's losses, the company's shares have surged 45.84% in the last
one month and 70.28% in the previous three months, outperforming the S&P 500,
which has gained 2.44% and 8.81% during the respective periods. Furthermore,
Endo Health Solutions Inc.'s stock is trading above its 50-day and 200-day
moving averages of $50.32 and $39.53, respectively. Sign up and read the
complimentary report on ENDP at:
On Tuesday, Allergan Inc.'s stock ended the day at $97.39, which is 0.52%
lower than the previous day's closing price of $97.90. The company's shares
fluctuated between $97.37 and $98.03 during the trading session. A total of
1.60 million shares were traded, which is below the daily average volume of
2.06 million. Despite Tuesday's losses, the company's shares have gained 4.92%
in the last one-month and 9.24% in the previous three months, outperforming
the S&P 500, which has gained 2.44% and 8.81% during the respective periods.
Additionally, Allergan Inc.'s stock is trading above its 50-day moving average
of $91.87. The free report on AGN can be downloaded by signing up now at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Phone #: + 1 (646) 396-9126 Contact Name: Peter F. Jones Email ID:
Press spacebar to pause and continue. Press esc to stop.